stopping semaglutide after weight loss Why Half of Drug Users Quit Within a Year How to Not Gain Weight

The FDA is committed to making sure that promotional communications for prescription drugs are "truthful, balanced and accurately communicated," according to an email from Emily Hilliard, a spokeswoman for the Department of Health and Human Services, the parent agency for the FDA

This hormonal cascade also leads to an increased heart rate, higher blood pressure, greater blood flow to the muscles, and heightened tension and stress sensitivity

(PubMed) Carroll D, Ring C, Suter M, Willemsen G

Other Double Agonists and Triple Agonist Beyond tirzepatide, pharmaceutical companies have developed additional dual receptor agonists targeting GLP-1 and glucagon (GCG) as well as triple receptor agonists.210 Mazdutide represents the most recent advancement in GLP-1/GCG dual receptor agonists;211213 this agent, co-developed by Cinda Biology and Lilly Pharmaceutical, received marketing approval in China on June 27, 2025